WST monthly performance report
Explore WST's monthly returns, drawdown, and seasonality trends — updated every month.
WST monthly report
—
Key takeaways
- West Pharmaceutical Services (WST) closed September 2026 at $362.01, up 6.13% for the month and +40.12% over the trailing 12 months.
- Year-to-date, WST is +31.57%, outperforming the S&P 500 which has returned +10.58% YTD.
- The stock is trading +22.51% versus its 200-day moving average ($295.50), a bullish technical signal.
- Over the past three years, WST has underperformed the S&P 500 by −78.23%, with a relative strength index reading of 54.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
West Pharmaceutical Services ended September 2026 at $362.01, posting a monthly return of +6.13%. The S&P 500 returned −1.69% over the same window, leaving relative performance at +7.82%.
The current quarter stands at +0.84% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +22.51% versus the 200-day moving average ($295.50).
Year-to-date, WST is +31.57% against SPY +10.58%, a gap of +21.00%. The stock is currently −5.33% below its 52-week high, with maximum 3-year drawdown at −53.90%.
| Period | WST | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.82% | −0.44% | −0.38% |
| 1 Week | +7.44% | −1.10% | +8.54% |
| 1 Month | +6.13% | −1.69% | +7.82% |
| 3 Months | +10.09% | −0.10% | +10.20% |
| 6 Months | +51.95% | +13.21% | +38.73% |
| YTD | +31.57% | +10.58% | +21.00% |
| 12 Months | +40.12% | +14.25% | +25.87% |
| 3 Years | −8.16% | +70.07% | −78.23% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2026 | +18.73% |
| #2 | Jun 2026 | +11.21% |
| #3 | Aug 2023 | +10.56% |
| #4 | Mar 2024 | +10.42% |
| #5 | Nov 2023 | +10.20% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2025 | −31.97% |
| #2 | Jan 2026 | −16.00% |
| #3 | Oct 2023 | −15.17% |
| #4 | Apr 2024 | −9.66% |
| #5 | Sep 2023 | −7.79% |
| Quarter | Return |
|---|---|
| Q2 2025 | −2.27% |
| Q3 2025 | +19.89% |
| Q4 2025 | +4.88% |
| Q1 2026 | −8.90% |
| Q2 2026 | +43.23% |
| Q3 2026 (QTD) | +0.84% |
| Year | Return |
|---|---|
| 2023 | +49.62% |
| 2024 | −6.97% |
| 2025 | −16.00% |
| 2026 | +31.57% |
| Metric | Value |
|---|---|
| 52-Week High | $382.40 (2026-07-23) |
| 52-Week Low | $223.83 (2026-01-30) |
| Current Price | $362.01 |
| 200-Day Moving Average | $295.50 |
| Price vs 200DMA | +22.51% |
| 3-Year Maximum Drawdown | −53.90% (2025-04-08) |
| Current Drawdown from 52W High | −5.33% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 54 |
| 3-Year Excess Return vs S&P 500 | −78.23% |
| RS Peak | 101.1 (Oct 2023) |
| RS Trough | 36.7 (Feb 2025) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was WST's return for this report period?
WST returned +6.13% in the latest monthly window ending 2026-09-16.
Has WST outperformed SPY year to date?
YTD WST: +31.57% vs SPY: +10.58%.
What is WST's 12-month return?
+40.12% over the trailing 12 months.
Is WST above or below its 200-day moving average?
Price is +22.51% versus 200DMA ($295.50).
What is the maximum drawdown in the 3-year window?
−53.90% on 2025-04-08.